Medication
Medical device
Toxic exposure
Rideshare or injury
Disability or benefits
Something elseCurrent status and review dates
See when each campaign was checked and whether a private review is available.
A simpler way to find answers
Tell us what happened. We’ll help you find the right information.
Choose a starting point or search every current campaign. You stay in control of what you share.
What best describes your situation?
MedicationPrescription or over-the-counterMedical deviceImplants, devices, or equipmentToxic exposureChemicals, water, or environmentRideshare or injuryAccidents or unsafe situationsDisability or benefitsSSDI or other benefitsSomething elseSearch or browse every topic
Not sure? Browse every campaign topicPopular starting points
View all campaignsCampaigns people review often
A listed review path does not mean you qualify. Read the current status and criteria before submitting.
Depo-Provera
For people who used Depo-Provera or a generic equivalent and were later diagnosed with a brain meningioma.
Review availableRoundup
For people reviewing significant Roundup or glyphosate exposure and a later qualifying diagnosis.
Review availableTalcum powder
For people reviewing long-term cosmetic talc use and a later cancer diagnosis.
Information availableParagard
For people reviewing a Paragard IUD fracture, migration, or removal complication.
Review availableHernia mesh
For patients researching serious complications after a hernia mesh implant.
Information availableAFFF and PFAS
For firefighters, military personnel, airport workers, and others reviewing AFFF or PFAS exposure.
Review availableRideshare assault or injury
For riders or drivers harmed during a trip connected with a rideshare platform.
Review availableSocial Security Disability
For people whose medical condition may prevent substantial work and who want help reviewing SSDI eligibility.
Eligibility review availableComplete campaign directory
Search and filter campaignsEvery campaign, organized clearly
Public topics are grouped by what happened. Advertising and referral variants stay out of navigation and continue using their existing URLs.
Medications
View medication topicsMedical devices
View device topicsToxic exposure
- Chlorpyrifos
- AFFF and PFAS
- Paraquat
- Camp Lejeune
- Lung cancer
- Asbestos and lung cancer
- World Trade Center and VCF
Injury and abuse
View injury topicsDisability and benefits
View benefits topicsProperty
View property topicsHow it works
A guided path, built around you
Questions adapt to the campaign. Existing submission routes and backend validation remain in place.
- 1Choose what happenedStart with a category or search.
- 2Read the campaign informationCheck status, criteria, and sources.
- 3Answer relevant questionsThe intake adapts to your answers.
- 4Receive the next stepA review does not guarantee acceptance.
Clear by design
Navigate with confidence
Official source links
Open the court or agency source behind each published update.
Evidence checklists
Understand which records and dates may help before starting a form.
Clear privacy choices
Review consent language before sharing your information.
Accessible everywhere
Use the same guided path on phone, tablet, or desktop.
Verified updates
Mass tort developments from the courts and agencies tracking them.
Latest source review
Latest update
Ninth Circuit
Uber passenger assault cases: evidence ruling stands
The appeals court declined to overturn the trial judge’s ruling on how the parties exchange evidence. It did not decide whether Uber was liable in any passenger’s case.
More recent updates
U.S. requests evidence order in Camp Lejeune cases
Summary and source
The Justice Department filed a reply supporting its request for an order requiring plaintiffs to provide evidence for their claims. The filing presents the government’s position. The court would decide whether to adopt the proposal.
FDA requires GLP-1 labels to address a possible risk of optic nerve injury
Summary and source
The FDA directed manufacturers to update the warnings for GLP-1 medicines after reviewing evidence about NAION, a rare optic nerve condition that can cause permanent vision loss. The agency described a potential increase in risk. Its review included clinical trials and observational studies.
Camp Lejeune parties submit competing proposals for use of Marine Corps records
Summary and source
Plaintiffs’ leaders and the United States filed separate proposals about how digitized Marine Corps records could be used. The government said it would agree to certain uses in court and opposed using the records in administrative claims or settlement efforts involving people outside the litigation. The filings asked the court to decide how the records could be used.
Start with information
Browse all campaignsFind the campaign that fits what happened.
Read the current status, review the source information, and continue only when you are comfortable.